Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Irish

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Blood|June 11, 2021
CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplantAlbert C Yeh, Antiopi Varelias, Anupama Reddy, et al.
Annals of Hematology|November 30, 2023
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agentsJan Philipp Bewersdorf, Rory M Shallis, Elad Sharon, et al.
Nature Immunology|March 27, 2025
Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
Blood|June 10, 2016
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatmentShahram Kordasti, Benedetta Costantini, Thomas Seidl, et al.
Hemasphere|May 17, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina A Tentori, Lin P Zhao, Benedetta Tinterri, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Blood|June 11, 2021
CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplantAlbert C Yeh, Antiopi Varelias, Anupama Reddy, et al.
Annals of Hematology|November 30, 2023
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agentsJan Philipp Bewersdorf, Rory M Shallis, Elad Sharon, et al.
Nature Immunology|March 27, 2025
Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19Glenda Canderan, Lyndsey M Muehling, Alexandra Kadl, et al.
Blood|June 10, 2016
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatmentShahram Kordasti, Benedetta Costantini, Thomas Seidl, et al.
Hemasphere|May 17, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina A Tentori, Lin P Zhao, Benedetta Tinterri, et al.
Pageof 14